254 related articles for article (PubMed ID: 21166843)
1. HbA(1c) in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study.
Pajunen P; Peltonen M; Eriksson JG; Ilanne-Parikka P; Aunola S; Keinänen-Kiukaanniemi S; Uusitupa M; Tuomilehto J; Lindström J;
Diabet Med; 2011 Jan; 28(1):36-42. PubMed ID: 21166843
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.
Ramachandran A; Snehalatha C; Samith Shetty A; Nanditha A
Diabet Med; 2012 Jan; 29(1):94-8. PubMed ID: 21790773
[TBL] [Abstract][Full Text] [Related]
3. HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience.
Bhowmik B; Diep LM; Munir SB; Rahman M; Wright E; Mahmood S; Afsana F; Ahmed T; Khan AK; Hussain A
Diabet Med; 2013 Mar; 30(3):e70-7. PubMed ID: 23199158
[TBL] [Abstract][Full Text] [Related]
4. What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our practice in 1998-2006?
Cosson E; Nguyen MT; Hamo-Tchatchouang E; Banu I; Chiheb S; Charnaux N; Valensi P
Diabet Med; 2011 May; 28(5):567-74. PubMed ID: 21480967
[TBL] [Abstract][Full Text] [Related]
5. Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study.
Mukai N; Doi Y; Ninomiya T; Hata J; Hirakawa Y; Fukuhara M; Iwase M; Kiyohara Y
Diabet Med; 2012 Jan; 29(1):99-106. PubMed ID: 21726278
[TBL] [Abstract][Full Text] [Related]
6. HbA(1c) measurement for the diagnosis of diabetes: is it enough?
Cavagnolli G; Comerlato J; Comerlato C; Renz PB; Gross JL; Camargo JL
Diabet Med; 2011 Jan; 28(1):31-5. PubMed ID: 21210540
[TBL] [Abstract][Full Text] [Related]
7. Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.
Hutchinson MS; Joakimsen RM; Njølstad I; Schirmer H; Figenschau Y; Jorde R
J Endocrinol Invest; 2012 Oct; 35(9):835-40. PubMed ID: 22186659
[TBL] [Abstract][Full Text] [Related]
8. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study.
Borg R; Vistisen D; Witte DR; Borch-Johnsen K
Diabet Med; 2010 Aug; 27(8):906-10. PubMed ID: 20653748
[TBL] [Abstract][Full Text] [Related]
9. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
[TBL] [Abstract][Full Text] [Related]
10. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
[TBL] [Abstract][Full Text] [Related]
11. Glycated hemoglobin vs. the oral glucose tolerance test for the exclusion of impaired glucose tolerance in high-risk individuals.
Santos-Rey K; Fernández-Riejos P; Mateo J; Sánchez-Margalet V; Goberna R
Clin Chem Lab Med; 2010 Dec; 48(12):1719-22. PubMed ID: 20846105
[TBL] [Abstract][Full Text] [Related]
12. Alterations in HbA(1c) with advancing age in subjects with normal glucose tolerance: Chandigarh Urban Diabetes Study (CUDS).
Ravikumar P; Bhansali A; Walia R; Shanmugasundar G; Ravikiran M
Diabet Med; 2011 May; 28(5):590-4. PubMed ID: 21244476
[TBL] [Abstract][Full Text] [Related]
13. Derivation & validation of glycosylated haemoglobin (HbA
Mohan A; Reddy SA; Sachan A; Sarma K; Kumar DP; Panchagnula MV; Rao PS; Kumar BS; Krishnaprasanthi P
Indian J Med Res; 2016 Aug; 144(2):220-228. PubMed ID: 27934801
[TBL] [Abstract][Full Text] [Related]
14. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
[TBL] [Abstract][Full Text] [Related]
15. High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8).
Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
Diabet Med; 2012 Oct; 29(10):1285-90. PubMed ID: 22486679
[TBL] [Abstract][Full Text] [Related]
16. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.
Bennett CM; Guo M; Dharmage SC
Diabet Med; 2007 Apr; 24(4):333-43. PubMed ID: 17367307
[TBL] [Abstract][Full Text] [Related]
17. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects.
Kim KS; Kim SK; Lee YK; Park SW; Cho YW
Diabet Med; 2008 Aug; 25(8):997-1000. PubMed ID: 18959616
[TBL] [Abstract][Full Text] [Related]
19. HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005).
Valdés S; Botas P; Delgado E; Alvarez F; Díaz-Cadórniga F
Diabetes Metab; 2011 Feb; 37(1):27-32. PubMed ID: 20934897
[TBL] [Abstract][Full Text] [Related]
20. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey.
Bao Y; Ma X; Li H; Zhou M; Hu C; Wu H; Tang J; Hou X; Xiang K; Jia W
BMJ; 2010 May; 340():c2249. PubMed ID: 20478961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
